Tencent-backed AI Firm QuantumPharm Breaks Ground with Hong Kong IPO

Tuesday, 4 June 2024, 00:00

The Hong Kong IPO of Tencent-backed QuantumPharm is significant as it is the first to leverage the year-old listing regime for pre-revenue tech companies. Operating as XtalPi, the company aims to raise up to HK$1.13 billion in a bid to foster adoption of the innovative Chapter 18C rule. This move is poised to set a precedent for tech outfits eyeing IPOs without revenue streams, potentially reshaping the IPO landscape in Hong Kong.
https://store.livarava.com/bbe3b5eb-2207-11ef-a3fb-9d5fa15a64d8.jpg
Tencent-backed AI Firm QuantumPharm Breaks Ground with Hong Kong IPO

QuantumPharm's Hong Kong IPO Marks a Significant Milestone

The Hong Kong IPO of QuantumPharm, a Tencent-backed AI company also known as XtalPi, is creating ripples in the market

Key Highlights:

  • First to Use Listing Regime: The IPO is the pioneer to utilize the Chapter 18C rule for pre-revenue tech firms
  • Sizeable Funding Goal: QuantumPharm aims to raise HK$1.13 billion in its inaugural IPO
  • Encouraging Market Adoption: The company's chairman aspires to set an example for other tech entities

With this unique listing, QuantumPharm is poised to influence IPO trends, highlighting the importance of innovative listing regimes in fostering capital growth.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe